Qingdao Qingxi Huada Genes Co., Ltd. announced that it will receive CNY 668,494,800 in an equity round of funding on February 9, 2021. The transaction will include participation from returning investor BGI Genomics Co., Ltd. (SZSE:300676). Out of total proceeds CNY 50,000,000 will added into registered capital, CNY618,494,800 as capital reserve. Post to the closing, the registered capital of the company will increase from CNY 50,000,000 to CNY 100,000,000. The transaction was approved by the board of directors of the company at its 29th session of 2nd directorate and the 27th session of 2nd supervisory board.